Valeda Light Delivery System

The Valeda Light Delivery System is the first approved treatment for Dry Age-Related Macular Degeneration (AMD) using Photobiomodulation (PBM). If you have Dry AMD, speaking to your eye care professional can help determine whether Valeda is the right option for you.

Who is suitable for Valeda treatment?

Valeda is specifically designed for individuals diagnosed with Dry Age-Related Macular Degeneration (AMD). The effectiveness of the treatment may depend on the stage of the disease, so a consultation with an eye care professional is essential. They will evaluate your condition and discuss whether Valeda could be beneficial for you.

Who should not have Valeda treatment?

Certain individuals should avoid Valeda treatment as a precaution. Patients with a known sensitivity to light exposure or those with a history of light-triggered neurological conditions, such as epilepsy or migraines, should not undergo this therapy. Additionally, those who have used photosensitising medications, whether in topical or injectable form, within the past 30 days should consult their eye care professional before proceeding with treatment.

What happens during Valeda treatment? Do I need to prepare?

Before treatment begins, patients will be asked to remove any glasses or contact lenses, although pupil dilation is not required. During the session, the patient sits comfortably in front of the Valeda Light Delivery System, and the procedure is carefully guided by a trained professional. Each treatment session lasts less than five minutes per eye, meaning a full session takes around ten minutes. Clinical studies recommend a treatment schedule of three sessions per week over a period of three to four weeks for optimal results. If a patient misses a session, it is advised to make up for it within the designated treatment period to maintain effectiveness.

What are the clinical benefits of Valeda?

Valeda has been shown to improve overall visual function, including enhanced clarity in reading eye charts and improved detailed vision. Clinical imaging has also revealed a reduction in drusen deposits, the protein build-ups that are commonly found in the eyes of individuals with Dry AMD. These improvements suggest that Valeda may help slow the progression of the disease and maintain vision quality.

Are there any side effects?

Photobiomodulation (PBM) is a low-level light therapy that has been safely used in various medical treatments for decades. Clinical studies involving Dry AMD patients have confirmed that PBM has an excellent safety profile. Valeda has been specifically designed to be safe for the eyes, and no treatment-related side effects have been reported in clinical trials.

What should I expect during and after treatment?

Following the session, some patients may experience temporary afterimages or a mild visual effect known as photostress, where the cells responsible for perceiving certain colours become briefly fatigued. However, this effect typically disappears within minutes. Patients can resume their normal activities immediately after treatment without any restrictions.

For further details on whether Valeda is the right choice for you, consult us today to explore your options.